dr. tara c gangadhar on atypical responses with immunotherapies in melanoma
Published 8 years ago • 181 plays • Length 0:58Download video MP4
Download video MP3
Similar videos
-
1:16
dr. tara gangadhar on single-agent versus dual immunotherapy approaches in melanoma
-
1:05
dr. tara gangadhar on epacadostat/ pembrolizumab combination
-
1:34
dr. gangadhar on combination regimens for melanoma
-
3:30
achieving durable responses in advanced melanoma
-
2:06
dr. tarhini discusses adjuvant therapy for melanoma
-
7:53
duration of immunotherapy in melanoma
-
2:08
dr tarhini on the utility of a prognostic model in advanced melanoma following ici treatment
-
4:54
efficacy of t-vec in early metastatic melanoma
-
7:03
patient selection in melanoma: immunotherapy vs targeted therapy
-
6:21
melanoma: helping patients understand immunotherapy
-
0:55
dr. triebel on novel immunotherapy combination in melanoma
-
2:43
clinical & tumor characteristics of patients with recurrent melanoma upon immunotherapy
-
1:50
nuances of immunotherapy-related aes in melanoma
-
2:44
less common side effects with immunotherapy in melanoma
-
1:21
dr. kluger on immunotherapy in melanoma
-
1:14
dr. daud on the combinations of immunotherapy for melanoma
-
10:28
responses to traditional chemotherapy vs immunotherapy
-
4:34
taking a chance on a melanoma clinical trial: mary elizabeth's immunotherapy story
-
1:20
dr. adams on whether prior lines of therapy impact response to immunotherapy in tnbc